Clinical trial

A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride

NCT00426842 · James J. Peters Veterans Affairs Medical Center, U.S. Fed · Completed

Key facts

NCT number NCT00426842
Title A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride
Official title A Dose Response Trial Using 5 and 10 mg. of Midodrine Hydrochloride to Treat Orthostatic Hypotension in Persons With SCI
Lead sponsor James J. Peters Veterans Affairs Medical Center, U.S. Fed
Status Completed
Phase Phase 2
Study type Interventional
Conditions Orthostatic Hypotension, Spinal Cord Injury
Intervention type Drug
Interventions Midodrine Hydrochloride
Enrollment 11
Start date Jan 1, 2007
Primary completion Mar 1, 2011
Completion Mar 1, 2011
First posted Jan 25, 2007
Last update posted Oct 10, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies